
March 5 (Reuters) - Aquestive Therapeutics Inc AQST.O:
AQUESTIVE THERAPEUTICS, INC. Q4 ADJUSTED EBITDA USD -11.029 MILLION
AQUESTIVE THERAPEUTICS, INC. Q4 PRETAX PROFIT USD -17.069 MILLION VERSUS. IBES ESTIMATE USD -12.7 MILLION
AQUESTIVE THERAPEUTICS, INC. Q4 INCOME FROM OPERATIONS USD -13.579 MILLION VERSUS. IBES ESTIMATE USD -9.57 MILLION
AQUESTIVE THERAPEUTICS, INC. Q4 NET INCOME USD -17.055 MILLION VERSUS. IBES ESTIMATE USD -12.8 MILLION
AQUESTIVE THERAPEUTICS, INC. Q4 REVENUE USD 11.867 MILLION VERSUS. IBES ESTIMATE USD 13.1 MILLION
: QTRLY LOSS PER SHARE $0.19
OUTLOOK FY TOTAL REVENUE $47MLN TO $56 MILLION
FY2025 REVENUE VIEW $53.0 MILLION -- LSEG IBES DATA
Further company coverage: AQST.O